search
Back to results

Intravenous Dexamethasone for Ropivacaine Axillary Block (ADEXA)

Primary Purpose

Postoperative Pain, Anesthesia, Forearm Injuries

Status
Completed
Phase
Phase 3
Locations
France
Study Type
Interventional
Intervention
intravenous dexamethasone
intravenous placebo
perineural ropivacaine
ultrasound guidance
Sponsored by
Centre Hospitalier Universitaire de Besancon
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Postoperative Pain focused on measuring anaesthetic techniques, regional anesthesia, brachial plexus block, Local Anesthetic, ropivacaine, analgesia, steroid, dexamethasone, placebo, adjuvant, ultrasound guided

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • ASA 1,2 et 3
  • surgery under axillary brachial plexus block
  • aged >18 years
  • signed information consent

Exclusion Criteria:

  • impaired coagulation
  • contraindication to regional anesthesia or technical impossibility
  • opioids or pain killers abuse or addiction
  • steroids consumption in the past 6 months
  • dementia or under administrative supervision
  • delay of surgery to short to allow regional anesthesia
  • pregnancy and breastfeeding
  • allergy and contraindication to dexamethasone or ropivacaine
  • anticipated bad observation of treatment
  • patient enrolled in another trial

Sites / Locations

  • CHRU de Besancon

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

intravenous dexamethasone

intravenous placebo

Arm Description

intravenous injection of 8mg (2ml) of dexamethasone during regional anesthesia

intravenous injection of 2ml of NaCl 0.9% during regional anesthesia

Outcomes

Primary Outcome Measures

Analgesia duration after axillary brachial plexus block

Secondary Outcome Measures

Motor block duration after axillary brachial plexus block Safety
Sensory block duration after axillary brachial plexus block
incidence of adverse event

Full Information

First Posted
July 22, 2016
Last Updated
January 30, 2018
Sponsor
Centre Hospitalier Universitaire de Besancon
search

1. Study Identification

Unique Protocol Identification Number
NCT02862327
Brief Title
Intravenous Dexamethasone for Ropivacaine Axillary Block
Acronym
ADEXA
Official Title
Intravenous Dexamethasone Versus Placebo for Ultrasound Guided Axillary Brachial Plexus Block With Ropivacaine: Randomised, Controlled, Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
October 2017
Overall Recruitment Status
Completed
Study Start Date
December 1, 2016 (Actual)
Primary Completion Date
March 16, 2017 (Actual)
Study Completion Date
September 16, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Universitaire de Besancon

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Prospective monocentric double-blind controlled randomised trial Aim is to assess prolonged postsurgical analgesia by intravenous dexamethasone versus intravenous placebo, after ultrasound guided axillary brachial plexus block

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postoperative Pain, Anesthesia, Forearm Injuries
Keywords
anaesthetic techniques, regional anesthesia, brachial plexus block, Local Anesthetic, ropivacaine, analgesia, steroid, dexamethasone, placebo, adjuvant, ultrasound guided

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
99 (Actual)

8. Arms, Groups, and Interventions

Arm Title
intravenous dexamethasone
Arm Type
Active Comparator
Arm Description
intravenous injection of 8mg (2ml) of dexamethasone during regional anesthesia
Arm Title
intravenous placebo
Arm Type
Placebo Comparator
Arm Description
intravenous injection of 2ml of NaCl 0.9% during regional anesthesia
Intervention Type
Drug
Intervention Name(s)
intravenous dexamethasone
Other Intervention Name(s)
DEXAMETHASONE MYLAN code UCD 9223084 3400892230849
Intervention Description
intravenous injection of dexamethasone
Intervention Type
Drug
Intervention Name(s)
intravenous placebo
Intervention Description
intravenous injection of placebo
Intervention Type
Drug
Intervention Name(s)
perineural ropivacaine
Intervention Description
brachial plexus block with perineural injection of Ropivacaine in the axillary fossa
Intervention Type
Other
Intervention Name(s)
ultrasound guidance
Intervention Description
ultrasound guidance for brachial plexus block in the axillary fossa
Primary Outcome Measure Information:
Title
Analgesia duration after axillary brachial plexus block
Time Frame
time to first pain at surgical site, an average of 24 hours
Secondary Outcome Measure Information:
Title
Motor block duration after axillary brachial plexus block Safety
Time Frame
up to block recovery, an average of 24 hours
Title
Sensory block duration after axillary brachial plexus block
Time Frame
up to block recovery, an average of 24 hours
Title
incidence of adverse event
Time Frame
6 month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ASA 1,2 et 3 surgery under axillary brachial plexus block aged >18 years signed information consent Exclusion Criteria: impaired coagulation contraindication to regional anesthesia or technical impossibility opioids or pain killers abuse or addiction steroids consumption in the past 6 months dementia or under administrative supervision delay of surgery to short to allow regional anesthesia pregnancy and breastfeeding allergy and contraindication to dexamethasone or ropivacaine anticipated bad observation of treatment patient enrolled in another trial
Facility Information:
Facility Name
CHRU de Besancon
City
Besancon
ZIP/Postal Code
25000
Country
France

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
30777900
Citation
Clement JC, Besch G, Puyraveau M, Grelet T, Ferreira D, Vettoretti L, Pili-Floury S, Samain E, Berthier F. Clinical effectiveness of single dose of intravenous dexamethasone on the duration of ropivacaine axillary brachial plexus block: the randomized placebo-controlled ADEXA trial. Reg Anesth Pain Med. 2019 Mar;44(3):e100035. doi: 10.1136/rapm-2018-100035.
Results Reference
derived

Learn more about this trial

Intravenous Dexamethasone for Ropivacaine Axillary Block

We'll reach out to this number within 24 hrs